The recruitment of leukocytes is essential for the immune response, not only in initiating but also in resolving inflammation. This process is critical for maintaining homeostasis, promoting tissue repair, and preventing excessive immune-mediated damage. Effective leukocyte recruitment ensures that immune cells are directed to sites of infection, injury, or inflammation, enabling both acute defense and the resolution phase that restores tissue integrity.
Leukocyte migration is orchestrated by a sophisticated network of signals, including chemokines, cytokines, and adhesion molecules, which govern their movement from the bloodstream into affected tissues and their navigation through different tissue environments. During the resolution phase of inflammation, these signals shift to promote the clearance of apoptotic cells, limit further immune cell infiltration, and support tissue remodeling. Dysregulation of this finely tuned process can lead to chronic inflammation, impaired healing, or pathological conditions such as autoimmune diseases and fibrosis.
A crucial aspect of leukocyte recruitment studies is the role of adhesion molecules like selectins and integrins, which mediate the initial tethering and rolling of immune cells along the vascular endothelium. Chemokines establish gradients that guide leukocytes to specific sites, with distinct roles during different inflammatory phases. For instance, neutrophils are rapidly mobilized during acute inflammation to contain infections, but their activity must be curtailed to prevent excessive tissue damage. Conversely, macrophages and regulatory T cells play central roles in resolving inflammation by clearing debris and secreting anti-inflammatory cytokines.
The transition from acute to resolving inflammation highlights the importance of balanced leukocyte recruitment. In autoimmune diseases, dysregulated recruitment of monocytes and T cells exacerbates tissue damage, while in chronic wounds, insufficient recruitment of reparative cells impairs healing. Understanding the dynamics of leukocyte subsets, including specialized neutrophil populations and tissue-resident macrophages, is critical for identifying therapeutic targets that can modulate inflammation resolution.
Therapeutic strategies aimed at modulating leukocyte recruitment are of particular interest. Integrin blockers, chemokine receptor antagonists, and pro-resolving mediators offer promising avenues to restore immune balance. Advances in imaging technologies, single-cell sequencing, and in vitro models have provided new insights into the dynamic behavior of leukocytes during inflammation and resolution, revealing cell-specific pathways and intercellular interactions. However, significant gaps remain, particularly in elucidating the recruitment mechanisms of less-studied cell types and their roles in resolving inflammation.
This collection seeks to advance our understanding of leukocyte recruitment across different phases of inflammation, with a focus on mechanisms that facilitate resolution of inflammation. By exploring fundamental processes, the contributions of diverse immune cell types, and innovative therapeutic approaches, this collection aims to bridge knowledge gaps, foster translational research, and enhance strategies for promoting immune homeostasis and patient recovery.
Areas of interest for this Research Topic include but are not limited to:
- Therapeutic strategies targeting leukocyte recruitment in resolution of inflammation
- Regulation and modulation of leukocyte recruitment during inflammation and resolution
- Chemotaxis and chemotactic molecules in the resolution phase of inflammation
- Distinct roles of leukocyte subsets in resolving acute versus chronic inflammatory responses
- Mechanisms limiting leukocyte recruitment to support inflammation resolution
The recruitment of leukocytes is essential for the immune response, not only in initiating but also in resolving inflammation. This process is critical for maintaining homeostasis, promoting tissue repair, and preventing excessive immune-mediated damage. Effective leukocyte recruitment ensures that immune cells are directed to sites of infection, injury, or inflammation, enabling both acute defense and the resolution phase that restores tissue integrity.
Leukocyte migration is orchestrated by a sophisticated network of signals, including chemokines, cytokines, and adhesion molecules, which govern their movement from the bloodstream into affected tissues and their navigation through different tissue environments. During the resolution phase of inflammation, these signals shift to promote the clearance of apoptotic cells, limit further immune cell infiltration, and support tissue remodeling. Dysregulation of this finely tuned process can lead to chronic inflammation, impaired healing, or pathological conditions such as autoimmune diseases and fibrosis.
A crucial aspect of leukocyte recruitment studies is the role of adhesion molecules like selectins and integrins, which mediate the initial tethering and rolling of immune cells along the vascular endothelium. Chemokines establish gradients that guide leukocytes to specific sites, with distinct roles during different inflammatory phases. For instance, neutrophils are rapidly mobilized during acute inflammation to contain infections, but their activity must be curtailed to prevent excessive tissue damage. Conversely, macrophages and regulatory T cells play central roles in resolving inflammation by clearing debris and secreting anti-inflammatory cytokines.
The transition from acute to resolving inflammation highlights the importance of balanced leukocyte recruitment. In autoimmune diseases, dysregulated recruitment of monocytes and T cells exacerbates tissue damage, while in chronic wounds, insufficient recruitment of reparative cells impairs healing. Understanding the dynamics of leukocyte subsets, including specialized neutrophil populations and tissue-resident macrophages, is critical for identifying therapeutic targets that can modulate inflammation resolution.
Therapeutic strategies aimed at modulating leukocyte recruitment are of particular interest. Integrin blockers, chemokine receptor antagonists, and pro-resolving mediators offer promising avenues to restore immune balance. Advances in imaging technologies, single-cell sequencing, and in vitro models have provided new insights into the dynamic behavior of leukocytes during inflammation and resolution, revealing cell-specific pathways and intercellular interactions. However, significant gaps remain, particularly in elucidating the recruitment mechanisms of less-studied cell types and their roles in resolving inflammation.
This collection seeks to advance our understanding of leukocyte recruitment across different phases of inflammation, with a focus on mechanisms that facilitate resolution of inflammation. By exploring fundamental processes, the contributions of diverse immune cell types, and innovative therapeutic approaches, this collection aims to bridge knowledge gaps, foster translational research, and enhance strategies for promoting immune homeostasis and patient recovery.
Areas of interest for this Research Topic include but are not limited to:
- Therapeutic strategies targeting leukocyte recruitment in resolution of inflammation
- Regulation and modulation of leukocyte recruitment during inflammation and resolution
- Chemotaxis and chemotactic molecules in the resolution phase of inflammation
- Distinct roles of leukocyte subsets in resolving acute versus chronic inflammatory responses
- Mechanisms limiting leukocyte recruitment to support inflammation resolution